Replies to post #342044 on Innovation Pharmaceuticals Inc (IPIX)

[TheDane]

Excellent points! Thanks making them.

[farrell90]

The exact quotation:

"Brilacidin’s potent in vitro inhibition of the Washington and Italian strains of SARS-CoV-2 support its potential to inhibit emerging coronavirus mutations (variants), such as those in the United Kingdom, Denmark and South Africa"

https://www.globenewswire.com/news-release/2020/12/21/2148511/0/en/FDA-Grants-IND-Approval-for-Phase-2-Clinical-Trial-of-Innovation-Pharmaceuticals-Brilacidin-for-Treating-COVID-19.html

The PR omits Brilacidin has been found effective against the coronovirus responsible for upper respiratory infections as well as other Coronaviruses to be reported in a separate paper.

"independent preliminary laboratory research suggests Brilacidin, the Company’s flagship defensin mimetic, has the potential to treat other endemic human coronaviruses (H-CoVs), such as those causing common colds, and not just SARS-CoV-2, the novel coronavirus responsible for the ongoing global COVID-19 pandemic. Research shows Brilacidin exerted potent in vitro inhibition of multiple strains of H-CoVs. On completion of testing, the H-CoV findings are expected to be submitted for peer-review publication."

http://www.ipharminc.com/press-release/2020/11/30/innovation-pharmaceuticals-covid-19-clinical-trial-to-support-additional-development-of-brilacidin-as-a-pan-coronavirus-therapeutic

http://www.ipharminc.com/press-release/2020/12/21/fda-grants-ind-approval-for-phase-2-clinical-trial-of-innovation-pharmaceuticals-brilacidin-for-treating-covid-19

No sign of pecuniary intent in my opinion.

GLTA Farrell

[frenchbroad]

*Perhaps you're aware that unscrupulous actors will twist and embellish facts - rendering said facts as half-truths - for financial benefit?* Oh oui. I have environ .6% Ipix action.

[steelyeye]

Citing the letter of the law, not the spirit... so call all the bs you like, but next time include the context of the entire paragraph.

In in vitro studies, Brilacidin was found to be a potent inhibitor of all variants of SARS-CoV-2, from the Washington to the Italian, from the English to the Danish and South African variants. Another interesting fact, which emerged from the preclinical study, is the effectiveness of Brilacidin on other coronaviruses that infect humans, in addition to SARS-CoV-2, such that it can be defined as a "pan-coronavirus" drug.

If Brilacidin pops the viral envelope in this upcoming trial, pan-corona becomes the accurate phrase. As you know, it did just that in the gov. lab.